Michael Rice

This profile gathers the share dealings of Michael Rice in Biolife Solutions Inc, where the filings describe the role as chief executive. The record holds 243 filings, for trades running from 13 May 2014 to 30 October 2023.

Both buying and selling appear: 2 purchases worth €36k, against 129 sales worth €25.7M. Taken together, the sales exceed the purchases by €25.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 22 share grants and 86 option exercises. In 2023 alone, the filings show no purchases and 14 sales.

Most recently, on 1 November 2023, the filings show an open-market sale worth €628k in Biolife Solutions Inc. The most recent open-market purchase was published on 14 May 2014, 4,561 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.